Investors and Share Holders
At CYduct Diagnostics, Inc. transparency of all activities and open communication are integral to our corporate philosophy.
All Company information aims to promote and strengthen the confidence of our investors and business partners, as well as those that utilize our products. Our intention is to provide you with real-time and comprehensive information about our business activities. We are committed to fulfilling our obligation and duty as a responsible corporation, ensuring that our behavior reflects our values and concern of our shareholders.
Stock Symbol: CYDX
Share Price & Financial Information Learn more →
CUSIP: 23256Q105 ¦ Investor Relations Tel: 888-545-9112
Issued & Outstanding Share: 4,991,239
Restricted Shares: 4,210,873
Free-Trading Shares: 780,366
Authorized Shares: 250,000,000
CYduct Diagnostics, Inc. Retains TPS Thayer PDF→
CYduct Diagnostics, Inc. Completes Strategic Acquisition PDF→
CYduct Diagnostics, Inc. enters Proteomic Research Agreement with Yale University PDF→
CYduct Diagnostics, Inc. Announces OTC Ticker Symbol Change to "CYDX" PDF→
CYduct Diagnostics, Inc. Signs LOI for Strategic Asset Acquisition PDF→
Solos Endoscopy, Inc. Acquires Assets of CYduct, LLC PDF→